Ratings The Cannabist Company Holdings Inc. NEO Exchange

Equities

CBST

CA13765Y1034

End-of-day quote NEO Exchange Other stock markets 18:00:00 2024-04-25 EDT			5-day change	1st Jan Change
0.35 ^CAD	-1.41%		-11.39%	-40.68%

04-26	The Cannabist Company Holdings Inc. and Airo Brands Continue Successful Partnership with Expansion into Pennsylvania and Virginia	CI
04-16	The Cannabist Company Holdings Inc. Announces Launch of Its Triple Seven Brand in New York and Florida	CI

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

For the past twelve months, EPS forecast has been revised upwards.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

Low profitability weakens the company.
The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Healthcare Facilities & Services

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
THE CANNABIST COMPANY HOLDINGS INC.	-40.68%	119M		C
ASCEND WELLNESS HOLDINGS, INC.	+31.96%	272M		-
AYR WELLNESS INC.	+33.74%	261M		-
ORGANIGRAM HOLDINGS INC.	+49.42%	194M		C
JUSHI HOLDINGS INC.	+44.98%	131M		-
IANTHUS CAPITAL HOLDINGS, INC.	-28.57%	121M	-	-
INTERCURE LTD.	+115.91%	119M	-	-
4FRONT VENTURES CORP.	0.00%	86.82M	-	-
BAKHU HOLDINGS, CORP.	+150.00%	75.33M	-	-
CANNARA BIOTECH INC.	+1.20%	55.24M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders